$KITE Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kite Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Kite Pharma, Inc.. Get notifications about new insider transactions in Kite Pharma, Inc. for free.

Page: < prev 1 2 3 4 5 6 7 ... 7 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	75.82	157	11,904	21,692	21.8 K to 21.7 K (-0.72 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	75.00	16,561	1,242,075	21,849	38.4 K to 21.8 K (-43.12 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	72.36	328	23,734	38,410	38.7 K to 38.4 K (-0.85 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	71.24	259	18,451	38,738	39 K to 38.7 K (-0.66 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	68.92	74	5,100	38,997	39.1 K to 39 K (-0.19 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	18,000	124,020	39,071	21.1 K to 39.1 K (+85.43 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Option Exercise	M	6.89	60,000	413,400	163,000
Mar 02 2017	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Sell	S	79.71	4,735	377,427	50,165	54.9 K to 50.2 K (-8.62 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Sell	S	79.11	55,265	4,372,014	54,900	110.2 K to 54.9 K (-50.17 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Buy	M	6.89	60,000	413,400	110,165	50.2 K to 110.2 K (+119.61 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	M	1.35	50,000	67,500	75,065
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Buy	M	1.35	50,000	67,500	75,065	25.1 K to 75.1 K (+199.48 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	76.77	2,800	214,942	25,065	27.9 K to 25.1 K (-10.05 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	77.03	6,000	462,200	115,017	121 K to 115 K (-4.96 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	72.27	10,000	722,673	121,017	131 K to 121 K (-7.63 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	M	53.90	2,400	129,360	161,301
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	M	53.90	16,299	878,516	163,701
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	M	51.43	31,601	1,625,239	52,499
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	79.92	400	31,968	18,664	19.1 K to 18.7 K (-2.10 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	79.26	600	47,556	19,064	19.7 K to 19.1 K (-3.05 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	76.93	200	15,386	19,664	19.9 K to 19.7 K (-1.01 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	75.52	200	15,104	19,864	20.1 K to 19.9 K (-1.00 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	73.64	100	7,364	20,064	20.2 K to 20.1 K (-0.50 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	72.69	200	14,538	20,164	20.4 K to 20.2 K (-0.98 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	71.23	200	14,246	20,364	20.6 K to 20.4 K (-0.97 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	70.29	300	21,087	20,564	20.9 K to 20.6 K (-1.44 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	68.95	200	13,790	20,864	21.1 K to 20.9 K (-0.95 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Buy	M	53.90	2,400	129,360	21,064	18.7 K to 21.1 K (+12.86 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	72.60	300	21,780	18,664	19 K to 18.7 K (-1.58 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	71.65	1,800	128,970	18,964	20.8 K to 19 K (-8.67 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	71.16	9,049	643,927	20,764	29.8 K to 20.8 K (-30.35 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	69.63	2,553	177,765	29,813	32.4 K to 29.8 K (-7.89 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	68.74	900	61,866	32,366	33.3 K to 32.4 K (-2.71 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	67.49	2,500	168,725	33,266	35.8 K to 33.3 K (-6.99 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	66.32	10,326	684,820	35,766	46.1 K to 35.8 K (-22.40 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	65.81	18,072	1,189,318	46,092	64.2 K to 46.1 K (-28.17 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	63.00	2,400	151,200	64,164	66.6 K to 64.2 K (-3.61 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Buy	M	53.90	16,299	878,516	66,564	50.3 K to 66.6 K (+32.43 %)
Mar 02 2017	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Buy	M	51.43	31,601	1,625,239	50,265	18.7 K to 50.3 K (+169.32 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	28,882	38,991	176,512
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	205,394
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	80.05	28,882	2,312,004	117,795	146.7 K to 117.8 K (-19.69 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	28,882	38,991	146,677	117.8 K to 146.7 K (+24.52 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	56.83	690	39,213	117,795	118.5 K to 117.8 K (-0.58 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	56.29	1,900	106,951	118,485	120.4 K to 118.5 K (-1.58 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	54.91	1,800	98,838	120,385	122.2 K to 120.4 K (-1.47 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	53.98	1,210	65,316	122,185	123.4 K to 122.2 K (-0.98 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	53.15	4,400	233,860	123,395	127.8 K to 123.4 K (-3.44 %)
Mar 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	127,795	117.8 K to 127.8 K (+8.49 %)
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	86,000
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.21	1,500	76,820	20,695	22.2 K to 20.7 K (-6.76 %)
Feb 06 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	22,195	20.7 K to 22.2 K (+7.25 %)
Feb 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	215,394
Feb 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.56	10,000	505,562	117,795	127.8 K to 117.8 K (-7.83 %)
Feb 01 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	127,795	117.8 K to 127.8 K (+8.49 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	87,500
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.00	1,500	75,000	20,695	22.2 K to 20.7 K (-6.76 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	22,195	20.7 K to 22.2 K (+7.25 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	225,394
Jan 10 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.13	10,000	501,289	117,795	127.8 K to 117.8 K (-7.83 %)
Jan 10 2017	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	127,795	117.8 K to 127.8 K (+8.49 %)
Jan 05 2017	KITE	Kite Pharma, Inc.	CLARK IAN T	Director	Option Exercise	A	45.95	17,130	787,124	17,130
Jan 05 2017	KITE	Kite Pharma, Inc.	CLARK IAN T	Director	Grant	A	0.00	4,690	0	4,690	0 to 4.7 K
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Option Exercise	A	47.72	159,700	7,620,884	159,700
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Grant	A	0.00	43,800	0	68,507	24.7 K to 68.5 K (+177.28 %)
Dec 29 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Gift	G	0.00	66,000	0	1,607,750	1.7 M to 1.6 M (-3.94 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Grant	A	0.00	10,600	0	60,235	49.6 K to 60.2 K (+21.36 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	MOORE TIMOTHY L.	EVP, Technical Oper ...	Option Exercise	A	46.09	30,700	1,414,963	30,700
Dec 27 2016	KITE	Kite Pharma, Inc.	MOORE TIMOTHY L.	EVP, Technical Oper ...	Grant	A	0.00	8,400	0	58,400	50 K to 58.4 K (+16.80 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Grant	A	0.00	5,600	0	20,695	15.1 K to 20.7 K (+37.10 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	JENKINSON PAUL L	Chief Financial Off ...	Option Exercise	A	46.09	24,200	1,115,378	24,200
Dec 27 2016	KITE	Kite Pharma, Inc.	JENKINSON PAUL L	Chief Financial Off ...	Grant	A	0.00	6,600	0	6,600	0 to 6.6 K
Dec 27 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	A	46.09	38,500	1,774,465	38,500
Dec 27 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Grant	A	0.00	10,600	0	18,664	8.1 K to 18.7 K (+131.45 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Option Exercise	A	46.09	90,600	4,175,754	90,600
Dec 27 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Grant	A	0.00	24,800	0	49,923	25.1 K to 49.9 K (+98.71 %)
Dec 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	A	46.09	90,600	4,175,754	90,600
Dec 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Grant	A	0.00	24,800	0	117,795	93 K to 117.8 K (+26.67 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.86	716	36,416	15,095	15.8 K to 15.1 K (-4.53 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Tomasello Shawn	Chief Commercial Of ...	Sell	S	50.86	4,901	249,265	49,635	54.5 K to 49.6 K (-8.99 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	50.86	936	47,605	8,064	9 K to 8.1 K (-10.40 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Sell	S	50.86	1,788	90,938	25,123	26.9 K to 25.1 K (-6.64 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.86	2,482	126,235	92,995	95.5 K to 93 K (-2.60 %)
Dec 22 2016	KITE	Kite Pharma, Inc.	Belldegrun Arie	Chairman, President ...	Sell	S	50.86	3,493	177,654	24,707	28.2 K to 24.7 K (-12.39 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	89,000
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	51.23	207	10,605	15,811	16 K to 15.8 K (-1.29 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.68	1,293	65,529	16,018	17.3 K to 16 K (-7.47 %)
Dec 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Nov 29 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	235,394
Nov 29 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	51.42	300	15,426	95,477	95.8 K to 95.5 K (-0.31 %)
Nov 29 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.37	9,700	488,589	95,777	105.5 K to 95.8 K (-9.20 %)
Nov 29 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,477	95.5 K to 105.5 K (+10.47 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	245,394
Nov 14 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	51.27	410	21,021	95,477	95.9 K to 95.5 K (-0.43 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.62	9,590	485,446	95,887	105.5 K to 95.9 K (-9.09 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,477	95.5 K to 105.5 K (+10.47 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	76,208
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.18	1,500	75,270	15,811	17.3 K to 15.8 K (-8.67 %)
Nov 14 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	77,708
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	55.51	170	9,437	15,811	16 K to 15.8 K (-1.06 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	54.72	1,330	72,778	15,981	17.3 K to 16 K (-7.68 %)
Oct 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Sep 28 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	255,394
Sep 28 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	54.13	10,000	541,300	95,477	105.5 K to 95.5 K (-9.48 %)
Sep 28 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,477	95.5 K to 105.5 K (+10.47 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	79,208
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	58.58	262	15,348	15,811	16.1 K to 15.8 K (-1.63 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	58.17	1,238	72,014	16,073	17.3 K to 16.1 K (-7.15 %)
Sep 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	17,311	15.8 K to 17.3 K (+9.49 %)
Aug 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	265,394
Aug 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	59.02	2,500	147,550	95,477	98 K to 95.5 K (-2.55 %)
Aug 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	58.03	7,500	435,225	97,977	105.5 K to 98 K (-7.11 %)
Aug 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,477	95.5 K to 105.5 K (+10.47 %)
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	M	51.43	2,400	123,432	84,100
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	M	51.43	33,500	1,722,905	86,500
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Option Exercise	A	51.43	120,000	6,171,600	120,000
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	63.01	2,400	151,229	9,000	11.4 K to 9 K (-21.05 %)
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Buy	M	51.43	2,400	123,432	11,400	9 K to 11.4 K (+26.67 %)
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Sell	S	60.08	33,500	2,012,596	9,000	42.5 K to 9 K (-78.82 %)
Aug 16 2016	KITE	Kite Pharma, Inc.	Kim Helen Susan	EVP, Business Devel ...	Buy	M	51.43	33,500	1,722,905	42,500	9 K to 42.5 K (+372.22 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	80,708
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	57.24	609	34,859	14,867	15.5 K to 14.9 K (-3.94 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	56.66	891	50,484	15,476	16.4 K to 15.5 K (-5.44 %)
Aug 02 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Jul 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	275,394
Jul 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.94	10,000	509,350	95,401	105.4 K to 95.4 K (-9.49 %)
Jul 26 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,401	95.4 K to 105.4 K (+10.48 %)
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	1,500	10,335	82,208
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	50.00	1,500	75,007	14,867	16.4 K to 14.9 K (-9.16 %)
Jul 05 2016	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	1,500	10,335	16,367	14.9 K to 16.4 K (+10.09 %)
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	285,394
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Option Exercise	M	1.35	10,000	13,500	295,394
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	50.15	10,000	501,484	95,401	105.4 K to 95.4 K (-9.49 %)
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,401	95.4 K to 105.4 K (+10.48 %)
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Sell	S	51.28	10,000	512,754	95,401	105.4 K to 95.4 K (-9.49 %)
Jun 27 2016	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	Chief Operating Off ...	Buy	M	1.35	10,000	13,500	105,401	95.4 K to 105.4 K (+10.48 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	58.38	4,000	233,516	27,865	31.9 K to 27.9 K (-12.55 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	57.56	5,000	287,805	131,017	136 K to 131 K (-3.68 %)
Jun 08 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Sell	S	58.25	5,000	291,260	136,017	141 K to 136 K (-3.55 %)
Jun 03 2016	KITE	Kite Pharma, Inc.	CHAMPSI FARAH	Director	Option Exercise	A	50.87	7,000	356,090	7,000
Jun 03 2016	KITE	Kite Pharma, Inc.	CHAMPSI FARAH	Director	Grant	A	0.00	1,950	0	21,616	19.7 K to 21.6 K (+9.92 %)
Jun 03 2016	KITE	Kite Pharma, Inc.	Humer Franz B	Director	Option Exercise	A	50.87	7,000	356,090	7,000
Jun 03 2016	KITE	Kite Pharma, Inc.	Humer Franz B	Director	Grant	A	0.00	1,950	0	4,021	2.1 K to 4 K (+94.16 %)
Jun 03 2016	KITE	Kite Pharma, Inc.	Peacock Jonathan M	Director	Option Exercise	A	50.87	7,000	356,090	7,000
Jun 03 2016	KITE	Kite Pharma, Inc.	Peacock Jonathan M	Director	Grant	A	0.00	1,950	0	67,964	66 K to 68 K (+2.95 %)
Jun 03 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Option Exercise	A	50.87	7,000	356,090	7,000
Jun 03 2016	KITE	Kite Pharma, Inc.	DOUMANI ROY	Director	Grant	A	0.00	1,950	0	141,017	139.1 K to 141 K (+1.40 %)

Page: < prev 1 2 3 4 5 6 7 ... 7 next >